Moomoo 24/7 ·  Apr 22 06:00
IDEAYA Biosciences Announces Selection of Move-Forward Phase 2 Expansion Dose for Ide397 Monotherapy in Mtap-Deletion Squamous Non-Small Cell Lung Cancer
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment